The expression of UBC9 was significantly higher in bladder cancer samples (84.9%, 90/106) compared with adjacent normal tissues (42.9%, 6/14) (P = 0.001) (Fig. 1C, Table S2). Here, UBE2I is linked to urinary bladder carcinoma.